The 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease has guidance for athletes & physical activity. Check out the guideline here:
#ACCAthleticHeart
#ClinicalGuidelines
Have you heard about the new CV ASC Registry Suite?
This registry is the first-of-its kind to easily provide data-driven insights on cardiac procedures performed in the ambulatory setting. Learn more:
#NCDR
Due to
@CDC
,
@WHO
#COVID19
reports, and in the best interest of our attendees and the
#CVD
patients whom they serve around the globe,
#ACC20
/
#WCCardio
is canceled. Virtual meeting options in the works. More here:
Understand the best practices for BP measurement for
#hypertension
patients w/ a 🆕 infographic, “Mismeasurement of BP in the Office: Finding the Common Mistakes.” Access the infographic, patient case quizzes & more free education w/ ACC's online course:
It’s time for a board of our own!
ACC,
@SCAI
,
@HFSA
&
@HRSonline
are uniting to request a new, independent medical board for CV medicine that would move away from
#MOC
and pursue a new competency approach to continuous certification. Learn more: .
🔑 Colchicine 0.5 mg daily is FDA-approved for secondary prevention in patients w/ coronary artery disease.
Read key points to remember from a state-of-the-art review on the long-term safety of low-dose colchicine for atherosclerosis:
#cvPrev
Mark your calendar for the FREE
#ACC20
/
#WCCardio
Virtual experience: March 28-30. Live access to 23 education sessions, such as LBCTs, Featured Clinical Research, Young Investigator Awards & keynotes. More here:
Dr.
@mirvatalasnag
is the recipient of the International Service Award.
We are proud to recognize her distinguished career dedicated to international collaboration & representing women on multiple medical committees worldwide.
#ACC23
#WCCardio
#ACCIntl
#ACCWIC
The PREVENT trial showed that preventive
#PCI
of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.
Read more:
#ACC24
💬 The complex pathophysiology of CKD in diabetes, together with its CV complications, provides many potential mechanistic targets for therapy -- Drs.
@saxodoc
&
@YHandelsmanMD
.
Read more on CV outcomes in patients w/
#diabetes
& kidney disease:
October is Sudden Cardiac Arrest Awareness Month!
420K+ Americans have an out-of-hospital SCA each year.
Survival rates can double or triple if more people take action and know what to do. Share ACC's SCA resources with your patients!
Over 420K Americans have an out-of-hospital sudden
#CardiacArrest
each year & about 10,200 are children. Giving CPR & using an AED within the first few minutes of SCA can greatly improve the chances of survival. Share our SCA
#CardioSmart
infographic:
Q: What are the optimal daily step counts needed to significantly reduce CV risk?
A: The optimal volume of 8,763 steps/day resulted in 60% risk reduction in all-cause mortality & 7,126 steps/day for 51% risk reduction of incident CVD
#cvPrev
Giving
#CPR
and using an AED within the first few minutes of sudden cardiac arrest can greatly improve a person's chances of survival. Help your patients understand SCA with this
#CardioSmart
infographic 👇
#ACCAthleticHeart
📍 DOACs should not be the standard treatment for patients w/ mechanical heart valves,
#AFib
w/ rheumatic mitral stenosis or antiphospholipid syndrome
Read key points from a
#JACC
state-of-the-art review on when DOACs should not be standard treatment:
The May issue of
#CardiologyMag
is out now!
This month's cover story looks specifically at innovations that are transforming structural heart interventions and expanding not only who can be treated but how they are treated. Read the full issue here:
Read the 10 key points to remember from the
@JACCJournals
State-of-the-Art Review on Advances in Multimodality Imaging in Cardio-Oncology written by the ACC's
#CardioOnc
and Imaging Councils:
#ACCImaging
In patients w/
#HeartFailure
who receive a primary prev ICD, the risk of developing atrial arrhythmia is influenced by the type of beta-blocker treatment. Carvedilol can significantly ↘️ the risk of atrial arrhythmias compared to metoprolol.
#JACCCEP
What is the impact of SGLT2i on AFib recurrence in patients with type 2 diabetes mellitus who have undergone an
#AFib
ablation?
Get the study details in
#JACCCEP
:
What are the incidence, characteristics, and outcomes of women presenting with sudden cardiac arrest during sports?
Read more about the study in
#JACC
:
#SportsCardio
The ISCHEMIA trial failed to show routine invasive therapy was associated w/ a reduction in major adverse ischemic events compared w/ optimal medical therapy among stable patients w/ moderate ischemia. Read the full details of the trial:
#ACCMidEastMed
✔️ SGLT2 inhibitors have been shown to ↘️ myofilament stiffness & extracellular matrix remodeling/fibrosis in the heart, improving diastolic function.
Read more 🔑 points from a state-of-the-art review on SGLT2 inhibitors in patients w/
#HFpEF
:
#cvPrev
Embrace the holiday magic in the heart of the concrete jungle while learning about the latest groundbreaking science from the authors who made direct contributions!
It's your last chance to join us for
#NYCVS23
! Register here:
👏 Thank you to
#ACC22
Chair Dr.
@PamelaBMorris
& Vice Chair Dr.
@DougDrachmanMD
for putting together a fantastic & innovative first-ever hybrid ACC Annual Scientific Session!
In this prospective multicenter study, a single dose of 120 mg inhaled flecainide acetate resulted in a high rate of conversion to sinus rhythm at 90 minutes without serious side effects.
Read more:
#AFib
Measurement & interpretation of hemodynamic data are integral aspects of treating patients w/
#HeartFailure
.
Read the key points from a state-of-the-art review on practical guidance for hemodynamic assessment by RHC in the management of HF. 🔗
#JACCHF
Let's start an ACC seal sculpture photo thread! 📸 We want to see your snapshots from
#ACC23
/
#WCCardio
in NOLA in front of one of the two photo op spots at the convention center. We'll go first...
#CardioTwitter
🆕 2024 Guideline for the Management of HCM
A key message from the guideline is the growing evidence regarding the beneficial effects of exercise for patients w/ HCM.
Read the full guideline here:
The initiation of beta-blocker therapy was found to be associated w/ a ↘️ in combined CV risk among a population of patients 66-105 y/o w/ angiographically documented CAD, LVEF ≥35% & no history of
#heartfailure
. Read more in
#JACC
:
🔑 Peripartum cardiomyopathy is the most common cause of
#HeartFailure
during pregnancy; however, many other types of cardiomyopathy are possible.
Read more key points to remember from a state-of-the-art review on cardio-obstetrics & HF:
#CardioOB
How do N-terminal pro–B-type natriuretic peptide levels change throughout pregnancy and what are their determinants?
Get the answer & study details here:
#JACCAdvances
#CardioObstetrics
🔑 Normal-flow low-gradient severe AS is defined as aortic valve area ≤1.0 cm2 w/ low gradient + normal flow and occurs in approx 20-30% of patients w/ severe AS.
Read more key points from a review comparing the US & European guidelines for NFLG AS:
Q: What is the effect of amyloidosis on outcomes of
#TAVR
?
A: There was no difference in in-hospital mortality or 30-day readmission rate after TAVR in patients w/ severe aortic stenosis & amyloidosis, compared to patients w/ lone AS.
More:
#JACCAdvances
New state-of-the-art review published in
#JACCCEP
aims to provide a comprehensive update on recent advances in conduction system pacing.
Read the top points from the review:
#HeartFailure
Q: Does the sensitivity and specificity for detection of
#AFib
differ between available smart devices?
Get the answer & details of the study here:
#cvPrev
#cvEP
We are deeply saddened by news of Dr. Alain Cribier’s passing. “The field of cardiology is forever changed because of his vision, leadership & persistence," said
#ACCPresident
@HadleyWilsonMD
. More on his life and impact here:
#TAVR
A state-of-the-art review on managing patients with moderate aortic stenosis was recently published in
#JACCIMG
. Read the highlights from the review here:
#HeartFailure
Read the key points to remember from a state-of-the-art review on low-dose colchicine for secondary prevention of coronary artery disease recently published as a
#JACC
Review Topic Of The Week:
#cvCAD
1 in 5 adults have an Lp(a) level that is too high. Use
#CardioSmart
’s Lp(a) Infographic to help patients understand this condition and how it might affect their heart.
#Cholesterol
#ACC24
🚨
#ACC24
Breaking News 🚨
The ACC.24 Late-Breaking Clinical Trials are out! Some of the trials being presented are:
◼️ RELIEVE-HF
◼️ EMPACT-MI
◼️ AEGIS-II
◼️ VICTORION-INITIATE
◼️ Step-HFpEF Dm
◼️ TELE-ACS
Learn more & see the full list of trials:
ACC recently created a pocket guide on nonstatin strategies & therapies for lowering LDL-C cholesterol. This tool guides clinician decision-making on the optimization of statin therapies in accordance w/ clinical guidelines & practical guidance.
#HeartFailure
affects millions of people around the world. 🌏
Check out our
#CardioSmart
infographic below & share with your patients so they can learn more about heart failure, its causes, symptoms & more.
#ACCAsia
The ACC has developed the point of care
#ultrasound
workbook to provide guidance on using POCUS in CV clinical practice.
🔑Key Points from the
#POCUS
Workbooks⬇️
The ACC, SCAI, HRS & HFSA have announced plans to submit an application to the ABMS requesting an independent medical board for CV medicine that would pursue a new competency approach to continuous certification.
Learn more:
#CardioTwitter
Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in
#JACC
:
🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present.
Read more key points from a state-of-the-art review on AiCM:
An 8 y/o male patient was brought to the emergency department after he collapsed at home. Based on the data from the
#EKG
, what is the etiology of this patient's clinical course and
#SuddenCardiacArrest
?
Read more & vote here:
#ACCEd
🆕 The "2024 AHA/ACC/Multisociety Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations for perioperative cardiovascular evaluation & management of adult patients undergoing noncardiac surgery.
Read the guideline in
#JACC
:
🔑 Patients should initially undergo coronary CT angiography to rule out the presence of left main disease or extensive three-vessel CAD in diabetic patients.
Read key points from a state-of-the-art review on optimizing management of stable angina:
More than 6 million Americans have
#heartfailure
. Because it's a lifelong condition, your patients must take an active role in their care to stay well. Explore our
#CardioSmart
tools:
#CardioOnc
Dr. Vivien Thomas shaped the future of CV care & left his mark on the field through perseverance & tenacity, this led to work that's served many children around the world, regardless of the color of their skin.
Read more:
#ACCDiversity
#BlackHistoryMonth
Dr. Fuster shares details on a study aimed to educate children through science.
Objectives of the Study:
1️⃣ Knowledge of how the body & heart work
2️⃣ Promote physical activity
3️⃣ Acquisition of healthy food habits
4️⃣ Encourage better management of emotions
#ACCMidEastMed
The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis & Management of
#AFib
provides updated guidance for clinicians and emphasizes a rhythm control strategy & the need for lifestyle & risk factor modification in addition to medical treatment. Read the full guideline:
📣 ACC.21 ANNOUNCEMENT: Due to the continued spread of COVID-19 and a sudden, sharp increase in travel restrictions,
#ACC21
will transition from a hybrid model to entirely virtual meeting. Learn more:
The STOPDAPT-2 trial showed 1-month DAPT was superior to 12-month DAPT at preventing net adverse ischemic events.
Read updates to the clinical trial regarding five-year results:
#cvPrev
Congratulations to Dr.
@BiykemB
– winner of the 2024 Bahr Award of Excellence! 🎉
#ACCAccreditation
applauds your extraordinary vision and leadership in advancing quality health care.
#ACCQuality24
There’s a need for continued research to better understand the underlying biological mechanism of the vaccine-associated myocarditis syndrome, identify risk predictors, & clarify the optimal clinical approach. Find out more here:
#COVID19
@JBToronto123
Artie learned how important it is to know
#CPR
and how to use an AED!
#SuddenCardiacArrest
survival odds could double or triple when people know how to take action. Artie is proud to be CPR certified and thinks everyone else should be too!
#ACC23
#WCCardio
SGLT2 inhibitors are recommended for many people with
#heartfailure
,
#cvCAD
and more.
The
#CardioSmart
infographic – What are SGLT2 inhibitors? – helps patients understand the benefits of this class of drugs, possible side effects and more.
#HFWeek2024
What are the clinical outcomes with biventricular pacing v. left bundle branch area pacing among patients undergoing cardiac resynchronization therapy?
Get the answer in
#JACC
:
The EMPA-KIDNEY trial showed empagliflozin has salutary effects on renal function and CV mortality among patients with CKD, with or without DM, who are already on appropriate doses of ACEi/ARB. Read updates here:
#HeartFailure
#CardiacRehab
is a supervised exercise program and provides education about nutrition, medication use & general lifestyle choices to help patients strengthen their hearts & lead healthier lives. Share
#CardioSmart
materials w/ your patients:
#CRWeek2024
In a large, multicenter
#cardiogenicshock
registry, complete hemodynamic assessment using pulmonary artery catheters prior to mechanical circulatory support is associated w/ lower in-hospital mortality compared with incomplete or no assessment. Learn more:
The ULTIMATE-DAPT trial showed that compared w/ standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation to ticagrelor monotherapy reduces bleeding without an increase in ischemic events at 1 year among patients undergoing PCI for ACS. Get the
Complete revascularization is recommended in patients presenting with an acute
#STEMI
without shock. Read the expert analysis here:
#PCI
@mirvatalasnag
Check it out! ACC President Dr.
@ditchhaporia
was featured in Times Square! ICYMI, learn about her goals and aspirations for ACC in our recent
#CardiologyMag
feature:
Discuss new insights into the management of patients with acute coronary syndromes with your colleagues this December at the New York Cardiovascular Symposium. Registration is open:
#NYCVS
#CardioTwitter
#CVD
#cvACS
What is the association of beta-blockers with
#heartfailure
hospitalization and death in patients with HF and ejection fraction ≥40%?
Get the answer in
#JACCHF
:
ICYMI: The RENAL-AF trial showed that apixaban 5 mg BID results in similar rates of bleeding and strokes as warfarin among patients with end-stage renal disease on hemodialysis.
#AHA19
#AFib
Congratulations to Dr.
@PamelaBMorris
, recipient of the Distinguished Service Award!
Dr. Morris has demonstrated exemplary leadership and commitment, serving as chair of the Annual Scientific Session during the high winds of the COVID-19 pandemic.
#ACC23
#WCCardio
✔️ Lp(a) is an independent risk factor for ASCVD & calcific valvular aortic stenosis.
✔️ Lp(a) exhibits significant race/ethnic variations, w/ levels highest among persons of African ancestry.
Read an expert analysis on w/ updates on Lp(a):
#cvPrev
Biomarkers of importance in pathways and prediction models in patients with coronary microvascular dysfunction were REN, GDF15, BNP (and its prohormone, NT-proBNP), ADM, CHI3L1, TRAILR2, and IL-6.
Read more in
#JACCAdvances
:
#cvEcho
ANOCA/INOCA are familiar yet under-addressed clinical entities, and the diagnosis and management of ANOCA/INOCA have presented challenges for physicians.
Learn more in
#CardiologyMag
:
ACC is proud to join with
@ABCardio1
and
@American_Heart
to denounce the incidents of racism and violence that continue to occur in communities across the U.S.
Disturbing times call for action. The ABC and our cardiovascular partners are extremely disturbed by violent acts that cut to the core of the lives of our community and denounce incidents of racism and violence.
Congratulations 🎉 to Dr.
@KBerlacher
for being named the next vice chair of the College’s Annual Scientific Session, starting with
#ACC23
. The College is honored to have you as an
#ACCEd
leader.
Read more:
#ACCLeadership
#ACCWIC
FDA Update:
@US_FDA
has approved sotagliflozin (Inpefa), the first dual SGLT1 and SGLT2 inhibitor for the treatment of heart failure, including HFpEF & HFrEF. Learn more ➡️